These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 21597678)
41. Changes in serum desnutrin levels in patients with acne vulgaris. Demir B; Ucak H; Cicek D; Aydin S; Erden I; Dertlioglu SB Eur J Dermatol; 2014; 24(5):589-93. PubMed ID: 25152512 [TBL] [Abstract][Full Text] [Related]
42. Comparison of insulin resistance in the various stages of chronic kidney disease and inflammation. Akalın N; Köroğlu M; Harmankaya Ö; Akay H; Kumbasar B Ren Fail; 2015 Mar; 37(2):237-40. PubMed ID: 25470080 [TBL] [Abstract][Full Text] [Related]
43. Resistance training improves hyperglycemia and dyslipidemia, highly prevalent among nonelderly, nondiabetic, chronically disabled stroke patients. Zou J; Wang Z; Qu Q; Wang L Arch Phys Med Rehabil; 2015 Jul; 96(7):1291-6. PubMed ID: 25827654 [TBL] [Abstract][Full Text] [Related]
44. Insulin Resistance Is Associated with Early Gastric Cancer: A Prospective Multicenter Case Control Study. Kwon HJ; Park MI; Park SJ; Moon W; Kim SE; Kim JH; Choi YJ; Lee SK Gut Liver; 2019 Mar; 13(2):154-160. PubMed ID: 30400721 [TBL] [Abstract][Full Text] [Related]
45. Plasma insulin, C-peptide and blood glucose and the risk of gastric cancer: the Japan Public Health Center-based prospective study. Hidaka A; Sasazuki S; Goto A; Sawada N; Shimazu T; Yamaji T; Iwasaki M; Inoue M; Noda M; Tajiri H; Tsugane S; Int J Cancer; 2015 Mar; 136(6):1402-10. PubMed ID: 25066446 [TBL] [Abstract][Full Text] [Related]
46. Insulin resistance in children with primary nephrotic syndrome and normal renal function. Jin J; Jin B; Huang S; Yuan Y; Ding G; Bao H; Chen Y; Han Y; Zhao F; Zhang A Pediatr Nephrol; 2012 Oct; 27(10):1901-9. PubMed ID: 22623021 [TBL] [Abstract][Full Text] [Related]
47. Desnutrin as a Biomarker for Insulin Resistance in Patients with Vitiligo Vulgaris. El-Hamd MA; Sedky A; Mahmoud AB; Abd El-Magid WM Indian J Dermatol; 2023; 68(4):366-371. PubMed ID: 37822413 [TBL] [Abstract][Full Text] [Related]
48. Metabolic syndrome in vitiligo patients among a semi-urban Maharashtrian population: A case control study. Sharma YK; Bansal P; Menon S; Prakash N Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S77-S80. PubMed ID: 28017282 [TBL] [Abstract][Full Text] [Related]
49. Detection of plasma and urinary monoamines and their metabolites in nonsegmental vitiligo. Shahin Z; Leheta TM; Abdel Hay RM; Abdel Aal HM; Rashed LA Acta Dermatovenerol Croat; 2012; 20(1):14-20. PubMed ID: 22507469 [TBL] [Abstract][Full Text] [Related]
51. Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis. Hernandez AV; Pasupuleti V; Benites-Zapata VA; Thota P; Deshpande A; Perez-Lopez FR Eur J Cancer; 2015 Dec; 51(18):2747-58. PubMed ID: 26597445 [TBL] [Abstract][Full Text] [Related]
52. Patients with vitiligo present fewer cardiovascular risk factors: results from a case-control study. Rodríguez-Martín M; de Paz NM; Mehtani P; Ferrer PC; Eliche MP; Martín BR; Sáez M; García M; Noda A J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):124-5. PubMed ID: 22176574 [No Abstract] [Full Text] [Related]
53. Hepato-splenic and lipid profile abnormalities--do they exist in children affected with vitiligo? Pietrzak A; Bartosińska J; Dybiec E; Chodorowska G; Krasowska D; Hercogova J; Lotti T Acta Dermatovenerol Croat; 2014; 22(1):19-25. PubMed ID: 24813837 [TBL] [Abstract][Full Text] [Related]
54. Increased Risk of Metabolic Syndrome in Patients with Vitiligo. Ataş H; Gönül M Balkan Med J; 2017 May; 34(3):219-225. PubMed ID: 28443562 [TBL] [Abstract][Full Text] [Related]
55. Distribution of HOMA-IR in Brazilian subjects with different body mass indexes. Ghiringhello MT; Vieira JG; Tachibana TT; Ferrer C; Maciel RM; Amioka PH; Hauache OM; de Oliveira CH; Khawali C; Reis AF Arq Bras Endocrinol Metabol; 2006 Jun; 50(3):573-4. PubMed ID: 16937003 [No Abstract] [Full Text] [Related]
56. Prolactin levels in the patients with vitiligo. Gönül M; Gül U; Kilinç C; Cakmak SK J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1454-5. PubMed ID: 19309421 [No Abstract] [Full Text] [Related]
57. A Notorious Trio! Inflammation, Metabolic Syndrome and Vitiligo. Mustafa AI; Hamed AM; Kadah AS; Fawzy EM; El Shimi OS Indian Dermatol Online J; 2023; 14(4):493-499. PubMed ID: 37521222 [TBL] [Abstract][Full Text] [Related]
58. Mucosal involvement in vitiligo: a comprehensive review of 241 cases. Kanwar AJ; Parsad D; De D J Eur Acad Dermatol Venereol; 2011 Nov; 25(11):1361-3. PubMed ID: 21108667 [No Abstract] [Full Text] [Related]
59. Assessment of survivin levels in serum in patients with vitiligo: A case-control study. Marie REM; Sarhan SAE; Abdel-Hamid AES; Eyada MMK Australas J Dermatol; 2021 Feb; 62(1):e112-e114. PubMed ID: 32757267 [No Abstract] [Full Text] [Related]
60. Serum zinc level in vitiligo: a case control study. Shameer P; Prasad PV; Kaviarasan PK Indian J Dermatol Venereol Leprol; 2005; 71(3):206-7. PubMed ID: 16394417 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]